Literature DB >> 31941717

Cannabinoid Modulation of Food-Cocaine Choice in Male Rhesus Monkeys.

William S John1, Thomas J Martin1, Michael A Nader2.   

Abstract

Marijuana and other cannabinoid compounds are widely used by cocaine users. Preclinical animal studies suggest that these compounds can increase the reinforcing effects of cocaine under some schedules of cocaine self-administration and reinstatement, but not in all cases. To date, no studies have used a food-cocaine concurrent choice procedure, which allows for assessment of drug effects on response allocation, not just changes in cocaine self-administration. The goal of the present study was to examine the effects of compounds differing in their efficacy at the cannabinoid receptor (CBR) on cocaine self-administration using a food-drug choice procedure in monkeys. Four adult male rhesus monkeys were trained to self-administer cocaine in the context of an alternative food (1.0-g banana-flavored pellets) reinforcer, such that complete cocaine dose-response curves (0, 0.003-0.1 mg/kg per injection) were determined each session. Monkeys were tested acutely with the CBR full agonist CP 55,940 (0.001-0.01 mg/kg); the CBR partial agonist Δ9-tetrahydrocannabinol (THC; 0.03-0.3 mg/kg), which is also the primary active ingredient in marijuana and the CBR antagonist rimonabant (0.3-3.0 mg/kg). Cocaine choice increased in a dose-dependent manner. Acute treatment with CP 55,940 decreased cocaine choice, whereas THC and rimonabant enhanced the reinforcing effects of cocaine. Chronic (7-day) treatment with CP 55,940 resulted in tolerance to the decreases in cocaine choice. These findings with Δ9-THC provide support for a potential mechanism for co-abuse of marijuana and cocaine. Additional research with chronic treatment with full CBR agonists on attenuating the reinforcing strength of cocaine is warranted. SIGNIFICANCE STATEMENT: Co-abuse of tetrahydrocannabinol and cocaine is a significant public health problem. The use of animal models allows for the determination of how cannabinoid receptor stimulation or blockade influences the reinforcing strength of cocaine.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31941717      PMCID: PMC7076528          DOI: 10.1124/jpet.119.263707

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  45 in total

1.  Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine.

Authors:  Małgorzata Filip; Anna Gołda; Magdalena Zaniewska; Andrew C McCreary; Ewa Nowak; Wacław Kolasiewicz; Edmund Przegaliński
Journal:  Pharmacol Rep       Date:  2006 Nov-Dec       Impact factor: 3.024

2.  Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens.

Authors:  Zheng-Xiong Xi; Jeremy G Gilbert; Xiao-Qing Peng; Arlene C Pak; Xia Li; Eliot L Gardner
Journal:  J Neurosci       Date:  2006-08-16       Impact factor: 6.167

3.  Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys.

Authors:  Paul W Czoty; Robert W Gould; Jennifer L Martelle; Michael A Nader
Journal:  Neuropsychopharmacology       Date:  2010-10-20       Impact factor: 7.853

4.  Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.

Authors:  Zuzana Justinova; Regina A Mangieri; Marco Bortolato; Svetlana I Chefer; Alexey G Mukhin; Jason R Clapper; Alvin R King; Godfrey H Redhi; Sevil Yasar; Daniele Piomelli; Steven R Goldberg
Journal:  Biol Psychiatry       Date:  2008-09-23       Impact factor: 13.382

Review 5.  Controversies in translational research: drug self-administration.

Authors:  Margaret Haney; Roger Spealman
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

6.  Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area.

Authors:  Huikun Wang; Tyler Treadway; Daniel P Covey; Joseph F Cheer; Carl R Lupica
Journal:  Cell Rep       Date:  2015-09-10       Impact factor: 9.423

7.  The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse.

Authors:  Sara Jane Ward; Marisa Rosenberg; Linda A Dykstra; Ellen A Walker
Journal:  Drug Alcohol Depend       Date:  2009-08-12       Impact factor: 4.492

8.  A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions.

Authors:  Laura Orio; Scott Edwards; Olivier George; Loren H Parsons; George F Koob
Journal:  J Neurosci       Date:  2009-04-15       Impact factor: 6.167

9.  Opposing roles of CB1 and CB2 cannabinoid receptors in the stimulant and rewarding effects of cocaine.

Authors:  Pedro H Gobira; Ana C Oliveira; Julia S Gomes; Vivian T da Silveira; Laila Asth; Juliana R Bastos; Edleusa M Batista; Ana C Issy; Bright N Okine; Antonio C de Oliveira; Fabiola M Ribeiro; Elaine A Del Bel; Daniele C Aguiar; David P Finn; Fabricio A Moreira
Journal:  Br J Pharmacol       Date:  2018-09-14       Impact factor: 8.739

10.  Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats.

Authors:  Foteini Delis; Alexia Polissidis; Nafsika Poulia; Zuzana Justinova; George G Nomikos; Steven R Goldberg; Katerina Antoniou
Journal:  Int J Neuropsychopharmacol       Date:  2017-03-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.